Pfizer sells bigger-than-expected stake in Haleon
Haleon
381.10p
16:34 20/12/24
0.13%
0.50p
Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
FTSE 100
8,084.61
17:04 20/12/24
n/a
n/a
FTSE 350
4,463.29
17:14 20/12/24
n/a
n/a
FTSE All-Share
4,421.11
17:04 20/12/24
n/a
n/a
Pfizer Inc.
$26.36
11:10 20/12/24
2.29%
$0.59
Pharmaceuticals & Biotechnology
19,761.12
17:14 20/12/24
0.06%
12.71
Pfizer was planning to sell around 630m shares in a public offering but the size of the offering was increased to just over 790.5m.
Haleon sold 594m ordinary shares at £3.08 each and 196.5m American Depository Shares (ADR) at $7.85 each. It raised around £1.8bn and $1.5bn, respectively.
The maker of Sensodyne toothpaste and Panadol said it has also agreed to buy back 102.2m ordinary shares from Pfizer off-market for around £315m.